These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12187331)

  • 1. Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470.
    Pu YS; Do KA; Luo W; Logothetis CJ; Lin SH
    Anticancer Drugs; 2002 Aug; 13(7):743-9. PubMed ID: 12187331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer model.
    Lin SH; Pu YS; Luo W; Wang Y; Logothetis CJ
    Anticancer Res; 1999; 19(1A):337-40. PubMed ID: 10226564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer.
    Hsieh JT; Earley K; Pong RC; Wang Y; Van NT; Lin SH
    Prostate; 1999 Sep; 41(1):31-8. PubMed ID: 10440873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells.
    Estrera VT; Luo W; Phan D; Earley K; Hixson DC; Lin SH
    Biochem Biophys Res Commun; 1999 Oct; 263(3):797-803. PubMed ID: 10512760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
    Lin SH; Pu YS
    Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound.
    Emoto M; Tachibana K; Iwasaki H; Kawarabayashi T
    Cancer Sci; 2007 Jun; 98(6):929-35. PubMed ID: 17433035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.
    Shusterman S; Grupp SA; Maris JM
    Med Pediatr Oncol; 2000 Dec; 35(6):673-6. PubMed ID: 11107144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
    J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
    Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
    Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line.
    Arisawa C; Kageyama Y; Kawakami S; Kihara K
    Urol Oncol; 2002; 7(6):229-34. PubMed ID: 12504843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-CAM1 expression: differential effects on morphology, differentiation state and suppression of human PC-3 prostate carcinoma cells.
    Comegys MM; Carreiro MP; Brown JF; Mazzacua A; Flanagan DL; Makarovskiy A; Lin SH; Hixson DC
    Oncogene; 1999 May; 18(21):3261-76. PubMed ID: 10359532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470.
    Kato H; Ishikura H; Kawarada Y; Furuya M; Kondo S; Kato H; Yoshiki T
    Jpn J Cancer Res; 2001 Jan; 92(1):67-73. PubMed ID: 11173546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implication of vascular endothelial growth factor (VEGF) in human head and neck cancer].
    Ueno Y
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):163-70. PubMed ID: 16615431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
    Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
    Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.
    Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT
    Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas.
    Ueda N; Kamata N; Hayashi E; Yokoyama K; Hoteiya T; Nagayama M
    Oral Oncol; 1999 Nov; 35(6):554-60. PubMed ID: 10705089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.